Submit for Reimbursement: If you prefer to use a standard credit card (perhaps to earn rewards points), you can do so and then submit the receipt to your FSA/HSA administrator for reimbursement
With the popularity of GLP-1 drugs for weight loss moving at warp speed, there's never been a better time to have the medical resources to draw upon

this off-label use is not backed by the same level of controlled human trial evidence as the lipodystrophy indication Known risks and side effects: Injection site reactions, including erythema, pruritus, pain, and bruising at the injection site Arthralgia (joint pain) and peripheral edema (fluid retention), recognized class effects of GH-axis stimulation Increases in blood glucose and reduced insulin sensitivity, with clinical trials showing a higher rate of elevated HbA1c and new-onset hyperglycemia versus placebo Formation of anti-tesamorelin antibodies, reported in a substantial proportion of treated patients, with unclear long-term clinical significance Contraindicated in people with active malignancy, pituitary or hypothalamic disruption, or pregnancy, per FDA labeling Evidence snapshot: The strongest evidence is a set of Phase 3 human randomized controlled trials that supported FDA approval of tesamorelin for reducing visceral abdominal fat in HIV-associated lipodystrophy (approved 2010), plus a separate placebo-controlled human RCT (Baker et al., 2012, Archives of Neurology) showing improved executive function in older adults

Both companies are developing pill versions of their treatments
International Union of Basic and Clinical Pharmacology
At Klinic in Portsmouth, Virginia, we prioritize branded, FDA-approved medications like Wegovy over compounded products